Vitamodo School · Bundle 5: Pharmacotherapy Without Myths · Brochure 7 of 10 · Version 1.0
Andris Saulitis, MD
For those who: are considering tapering a psychiatric medication, are in the process of tapering, or want to understand what the careful taper actually involves before deciding.
Not for those who: want a fast protocol for stopping medication. The careful taper takes the time the body needs, which is often substantially longer than the standard guidance allows.
What this is — the clinical reality
The decision to discontinue a psychiatric medication, taken with appropriate clinical support, is one of the most consequential clinical operations in modern psychopharmacology. It is also one of the most consistently mishandled. The standard guidance — taper over four to six weeks, reduce by twenty-five per cent each step — has been substantially outdated by the careful contemporary research on tapering, and patients following the standard guidance often experience withdrawal symptoms that are severe, prolonged, and that produce substantial clinical and emotional cost. The careful tapering literature, developed substantially over the past decade by Mark Horowitz, David Taylor, the patient-led communities, and the Maudsley Deprescribing Guidelines, has fundamentally revised the standard approach. This brochure is the working clinical material on what the careful taper actually looks like.
This brochure is for the reader currently considering discontinuation of a psychiatric medication, currently in the process of tapering, or wanting to understand what a careful taper would involve before making decisions about long-term use. It assumes you have read the preceding brochure on dependence versus addiction (Bundle 5 Brochure 6), or that you are willing to engage with the careful framework that brochure developed. The dependence framework is the foundation of this one; the taper is the practical clinical work that the framework supports.
A note before we go further. The careful taper is not a single recipe. It is a working partnership between patient and prescriber, paced by what the body actually allows, with substantial individual variation in how long the work takes and how it proceeds. The reader should not take the specific numbers in this brochure as prescriptions; they are illustrative of the broader framework, which then has to be applied to the specific medication, the specific duration of use, the specific patient situation. The substantive engagement with the prescriber, supplemented by the patient-led tapering community resources, is what produces the actual taper plan.
A second note. The careful tapering literature is, in honest assessment, substantially ahead of standard prescribing practice in many settings. If your prescriber has not engaged with the contemporary literature — the Maudsley Deprescribing Guidelines, the Horowitz work on hyperbolic tapering, the patient-led tapering community resources — the conversation you can have with them about your taper may be more limited than you need. Finding a prescriber who engages with the careful literature is, for many patients, part of the careful taper.
Three frames carry the discontinuation work.